Graves' disease trials in Netherlands

3 of 3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 2Active, not recruiting
  A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

  Where

  Dordrecht, Rotterdam

  Age

  18 years to 75 years

  People

  210 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07018323 · EU 2025-521920-31-00
• Phase 1Taking people
  Phase 1 Single Ascending and Multiple Ascending Dose Study with LCA-0321

  Where

  Groningen, Rotterdam, 's-Hertogenbosch

  Age

  18 years and over

  People

  22

  Run by

  Lycia Therapeutics Inc.

  See details and how to join2025-524053-14-00
• Phase 2Not yet taking people in Netherlands
  A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease

  Where

  Dordrecht, Rotterdam

  Age

  18 years and over

  People

  128 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to join2025-524001-33-00